Meg Kays

498 citations
16 papers · 396 indexed · h-index 9
Topics
Antibiotics Pharmacokinetics and Efficacy (8 papers)Antibiotic Resistance in Bacteria (3 papers)Poisoning and overdose treatments (2 papers)
Partner nations
United States

In The Last Decade

Meg Kays

15 papers receiving 376 citations

Peers

Meg Kays
Comparison fields: 5 of 69
  • Molecular Biology 153
  • Pharmacology 115
  • Molecular Medicine 97
  • Pulmonary and Respiratory Medicine 72
  • Epidemiology 65
Replace J. Mohler with:
J. Mohler France
A. M. Lovering United Kingdom
P. J. Wilkinson United Kingdom
J Woodcock United Kingdom
Nai‐Xun Chin United States
Sophie Magréault France
Angela M. Ristuccia United States
Josette Behra-Miellet France
Naoya Nishiyama Japan
D J Pohlod United States
Meg Kays relative to J. Mohler France J. Mohler's profile →
Citations per field
00.5×1.5×2.2×
J. Mohler · 1×
Citations per year

Countries citing papers authored by Meg Kays

Since Specialization
Citations

This map shows the geographic impact of Meg Kays's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Meg Kays with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Meg Kays more than expected).

Fields of papers citing papers by Meg Kays

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Meg Kays. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Meg Kays. The network helps show where Meg Kays may publish in the future.

Co-authorship network of co-authors of Meg Kays

This figure shows the co-authorship network connecting the top 25 collaborators of Meg Kays. A scholar is included among the top collaborators of Meg Kays based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Meg Kays. Meg Kays is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 0
2 10
3 1
4 26
5 45
6 5
7 121
8 12
9 1
10 77
11
Evaluation of cephalosporins/cephamycins with antianaerobic activity by integrating microbiologic and pharmacokinetic properties.
7
12 33
13 26
14
Pharmacokinetic evaluation of aztreonam in burn patients
4
15 1
16
Antibiotic prophylaxis and tourniquet inflation in total knee arthroplasty.
27

About Meg Kays

Meg Kays is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Pharmacology, having authored 16 papers that have together received 396 indexed citations. Recurring topics across this work include Antibiotics Pharmacokinetics and Efficacy (8 papers), Antibiotic Resistance in Bacteria (3 papers) and Poisoning and overdose treatments (2 papers). The work is most often cited by research in Molecular Medicine (97 citations), Applied Microbiology and Biotechnology (23 citations) and Endocrinology (35 citations). Meg Kays has collaborated with scholars based in United States. Frequent co-authors include Alice Prince, Kevin M. Sowinski, Lawrence V. Friedrich, Roger L. White, Lisa Saiman, G Cacalano, Brian R. Overholser, Dabney R. Yarbrough, John M. Graham and Richard J. Friedman. Their work appears in journals such as Journal of Clinical Investigation, Journal of Clinical Microbiology and Antimicrobial Agents and Chemotherapy.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026